OBJECTIVE: Blood coagulation and platelet activation are mutually dependent processes, but contribute differently to venous and arterial thrombosis. We investigated the interplay of these processes in vivo in a mouse model of arteriolar and venular thrombus formation. METHODS: Thrombus formation was studied by intravital (fluorescence) microscopy after topical application of FeCl3 on mouse mesenteric microvessels. RESULTS: Both in arterioles and venules, the thrombus-forming process relied on tissue factor-factor VII(a) interaction, collagen exposure, and glycoprotein VI-mediated platelet activation. Arterial thrombus formation was impaired by mild thrombin inhibition or platelet inhibition, while venous thrombosis was only suppressed by strong thrombin inhibition or by mild thrombin inhibition together with platelet inhibition. Phosphatidylserine-exposing platelets were present in thrombi of both vessel types, as detected with fluorescently labeled annexin A5. Injection of annexin A5 to shield exposed phosphatidylserine abolished thrombus formation in arterioles and venules, while mutant M1234-annexin A5 was ineffective. Arterial and venous thrombus formations were only slightly affected in mice carrying the factor V Leiden mutation, suggesting insensitivity to factor Va inactivation. CONCLUSIONS: In this microvascular model, the formation of both arterial and venous thrombi relies on collagen-induced platelet activation and tissue factor-induced thrombin generation. Activated, phosphatidylserine-exposing platelets play a key role in thrombus growth in arterioles and venules.
OBJECTIVE: Blood coagulation and platelet activation are mutually dependent processes, but contribute differently to venous and arterial thrombosis. We investigated the interplay of these processes in vivo in a mouse model of arteriolar and venular thrombus formation. METHODS:Thrombus formation was studied by intravital (fluorescence) microscopy after topical application of FeCl3 on mouse mesenteric microvessels. RESULTS: Both in arterioles and venules, the thrombus-forming process relied on tissue factor-factor VII(a) interaction, collagen exposure, and glycoprotein VI-mediated platelet activation. Arterial thrombus formation was impaired by mild thrombin inhibition or platelet inhibition, while venous thrombosis was only suppressed by strong thrombin inhibition or by mild thrombin inhibition together with platelet inhibition. Phosphatidylserine-exposing platelets were present in thrombi of both vessel types, as detected with fluorescently labeled annexin A5. Injection of annexin A5 to shield exposed phosphatidylserine abolished thrombus formation in arterioles and venules, while mutant M1234-annexin A5 was ineffective. Arterial and venous thrombus formations were only slightly affected in mice carrying the factor V Leiden mutation, suggesting insensitivity to factor Va inactivation. CONCLUSIONS: In this microvascular model, the formation of both arterial and venous thrombi relies on collagen-induced platelet activation and tissue factor-induced thrombin generation. Activated, phosphatidylserine-exposing platelets play a key role in thrombus growth in arterioles and venules.
Authors: Vu Minh Hua; Latasha Abeynaike; Elias Glaros; Heather Campbell; Leonardo Pasalic; Philip J Hogg; Vivien M Y Chen Journal: Blood Date: 2015-10-16 Impact factor: 22.113
Authors: John D Welsh; Timothy J Stalker; Roman Voronov; Ryan W Muthard; Maurizio Tomaiuolo; Scott L Diamond; Lawrence F Brass Journal: Blood Date: 2014-06-20 Impact factor: 22.113
Authors: Joanna L Sylman; Uranbileg Daalkhaijav; Ying Zhang; Elliot M Gray; Parsa A Farhang; Tiffany T Chu; Jevgenia Zilberman-Rudenko; Cristina Puy; Erik I Tucker; Stephanie A Smith; James H Morrissey; Travis W Walker; Xiaolin L Nan; András Gruber; Owen J T McCarty Journal: Ann Biomed Eng Date: 2016-12-08 Impact factor: 3.934
Authors: Karen Gilio; Roger van Kruchten; Attila Braun; Alejandro Berna-Erro; Marion A H Feijge; David Stegner; Paola E J van der Meijden; Marijke J E Kuijpers; David Varga-Szabo; Johan W M Heemskerk; Bernhard Nieswandt Journal: J Biol Chem Date: 2010-06-02 Impact factor: 5.157
Authors: Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk Journal: Haematologica Date: 2015-03-13 Impact factor: 9.941
Authors: Goran Rudez; Nicole A H Janssen; Evren Kilinc; Frank W G Leebeek; Miriam E Gerlofs-Nijland; Henri M H Spronk; Hugo ten Cate; Flemming R Cassee; Moniek P M de Maat Journal: Environ Health Perspect Date: 2009-02-22 Impact factor: 9.031
Authors: Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk Journal: PLoS One Date: 2010-04-29 Impact factor: 3.240